YourBio Health Expands Leadership Team for Future Success in Blood Collection Technology

In a strategic move to accelerate its growth, YourBio Health, a front-runner in the realm of remote blood collection technology, has recently appointed three key figures to its leadership team. These appointments aim to enhance the company’s ability to innovate and commercialize its groundbreaking products in the medical field.

On February 19, 2025, YourBio announced that Dr. Michael Mina, Dr. Chester Robson, and Mr. Thomas Briggs would be joining the executive team alongside CEO Paul Owen. This new leadership trifecta brings a wealth of experience in medical device innovation, clinical strategy, and commercial growth, setting the stage for transformative developments in blood collection.

The innovative Touch-Activated Phlebotomy (TAP®) device, credited as the first push-button blood collection technology, is at the heart of YourBio’s mission. This device utilizes microneedles to facilitate virtually painless blood draws, significantly streamlining the experience for patients. Today, their TAP products are utilized across a variety of settings including clinical trials, diagnostics, and wellness programs, enabling reliable and user-friendly at-home blood collection.

Mr. Owen expressed enthusiasm about the new appointments, emphasizing that the team is well-equipped to tackle the challenges posed by decentralized blood collection methods. He stated, “The board of directors and I assembled this leadership team based on their extensive knowledge of the hurdles related to blood collection. We believe their unified passion for innovation will enable us to significantly improve healthcare delivery.”

Dr. Mina enters the leadership role as Chief Scientific Officer, bringing with him a reputation for spearheading public health initiatives and improving community healthcare delivery. Previously, he played pivotal roles in various government and industry-led programs, most notably leading the U.S. government's Home Test to Treat initiative aimed at enhancing home and community healthcare services.

Dr. Robson joins as Chief Medical Officer, leveraging his vast experience in distributed care acquired through his former leadership roles at Walgreens. He is set to oversee the clinical strategy for YourBio’s blood collection technology, ensuring that the TAP device meets rigorous healthcare standards and can play a key role in evolving clinical practices.

Meanwhile, Mr. Briggs, appointed as Chief Growth Officer, brings two decades of commercial development experience from well-established biotech companies. His focus will be on expanding YourBio's market presence and driving the development of new partnerships in the biotechnology landscape, particularly centered on enhancing the user experience with TAP devices.

The company's ambition doesn’t end with the technology; it’s geared towards changing the perception of blood collection. Dr. Mina highlighted the crucial fact that nearly 20% of Americans shy away from medical care due to a fear of needles. His mission at YourBio is clear: transforming how patients experience blood draws through the application of innovative solutions.

Similarly, Dr. Robson reiterated that healthcare delivery is swiftly transitioning towards more decentralized models, making YourBio's technology indispensable in providing personalized and patient-friendly healthcare solutions. He envisions the TAP device as an integral component of this transition.

Mr. Briggs echoed this sentiment, noting the universal need for a modern solution to blood testing, particularly in the realm of clinical trials. He stated, “With the TAP device, we are replacing a technology that’s centuries old, catering to various blood testing needs while improving patient diversity in research.”

In conclusion, the restructured management team at YourBio Health is more than just a series of appointments; it represents a strategic vision for the future of blood collection technology. With a steadfast commitment to innovation and patient care, YourBio Health is poised to revolutionize the blood collection process, enhancing its accessibility and efficiency for both patients and healthcare providers alike. As they move forward, the combined expertise of this new team signals exciting developments on the horizon for the healthcare industry.